Search for:
Category

Submenue

Category
In Product Regulation & Liability

United Kingdom: Prohibitions against medical cannabis were eased almost 4 years ago. Has there been further relaxation since?

by 3 Mins Read

In November 2018, the law surrounding the prescription of medical cannabis was changed by the British Home Office. Promising developments occurred in the year after this, including the approval of a cannabis based drug for childhood epilepsy and the opening of London’s first medical cannabis clinic with 150 patients on a waiting list. Nevertheless, almost four years on from the relaxation of barriers to access, it appears that minimal tangible progress has been made, particularly as it pertains to patient access which was the key motivation triggering government officials such as Home Secretary Sajid Javid to change the law in 2018.

Read More
In Product Regulation & Liability

Germany: German government announces bill to drastically slash drug reimbursement

by , and 7 Mins Read

On 8 July 2022, the German Health Ministry officially shared the second edition of a new bill referred to as the Act for Financial Stability of the Public Health Insurance (GKV-Finanzstabilisierungsgesetz). The bill is still subject to discussions with stakeholders and several rounds of congress hearings. If ultimately implemented, which is a likely scenario, pharma companies will face several painful cutbacks on the statutory reimbursement of prescription-only medicinal products.

In ESG

Off the Shelf: The Global Consumer Goods & Retail Industry Video Podcast

by , , , , , , , , , and 4 Mins Read

Off the Shelf, the Global Consumer Goods & Retail (CG&R) Industry Video Podcast, provides short practical legal insights into the key issues affecting consumer goods and retail businesses. Increasingly, the desire for CG&R companies to include references and claims about their sustainability stems from the demand by consumers to know more about the brands they engage with, particularly their sustainability credentials, and this is driving this trend for green/sustainability claims to be increasingly featured and promoted.

In Corporate Compliance

Global: Annual Compliance Conference (6 September – 6 October 2022)

by , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and 1 Min Read

Annual Compliance Conference

Our popular Annual Compliance Conference, which attracts over 6,000 in-house senior legal and compliance professionals from across the world, will be held across five weeks from 6 September – 6 October 2022. We will be virtually delivering our cutting-edge insights and guidance on key global compliance, investigations and ethics issues. Our global experts will provide practical insights and analysis on significant developments across:
– anti-bribery
– corruption and economic crime
– customs and FTAs
– ESG, supply chain and product compliance
– antitrust and competition
– export controls, sanctions and foreign investment

Click https://www.bakermckenzie.com/en/insight/events/2022/10/annual-compliance-conference to register your interest in joining us virtually at this must attend global compliance conference for senior in-house legal and compliance professionals.

In Trade and Foreign Investment

Argentina: Central Bank Communication “A” 7532 – Amendments to the foreign exchange regime

by , and 2 Mins Read

By means of Communication “A” 7532, the Central Bank of Argentina established new restrictions regarding access to the foreign exchange market for the payment of imports of goods and the payment of imports of services to unrelated counterparties, among others.

Read More
In Antitrust / Competition

China: Landmark Anti-Monopoly Law reforms signal more modernized antitrust enforcement

by , , and 3 Mins Read

On 24 June 2022, China’s National Peoples’ Congress approved far reaching amendments to China’s Anti-Monopoly Law which become effective from 1 August 2022 (“AML Amendments”).
Alongside the AML Amendments, the State Administration for Market Regulation has issued for public comment proposed updates to key implementing rules and regulations concerning cartels and vertical restraints, abuse of dominance, merger control and abuse of IP rights.
Of particular relevance to business operations in China and M&A activity, the AML Amendments include stricter penalties for antitrust violations; increased enforcement powers; revised thresholds for merger control; an express prohibition of hub & spoke arrangements; potential exemptions/defenses for certain vertical restraints including resale price maintenance, and continued scrutiny of the platform economy.

In Antitrust / Competition

Mexico: COFECE initiates a competition analysis into the digital financial services market

by , , and 2 Mins Read

On 22 June 2022, the Commissioners of the Federal Economic Competition Commission (COFECE) approved conducting a research study on competition in the digital financial services market. The Market Study’s purpose is to analyze the structure, operation and regulatory framework of the digital financial services sector in Mexico.
The digital financial services considered in the study include electronic payment and crowdfunding services, those offered by Financial Technology Institutions, also known as Fintech, which are regulated by the Law to Regulate Financial Technology Institutions.
According to COFECE, the Market Study is important because the financial services sector contributes a significant percentage of the country’s Gross Domestic Product, and digital financial services can also influence the financial options available to users and facilitates credit access to small and medium-sized companies.

In Product Regulation & Liability

Italy: Bills to implement Regulation (EU) 2017/745 and Regulation (EU) 2017/746 on medical devices and in vitro diagnostic medical devices

by and 2 Mins Read

On 5 May 2022, the Council of Ministers preliminarily approved the bill to adapt the Italian legislation to the provisions of Regulation (EU) 2017/745 on medical devices and Regulation (EU) 2017/746 on in vitro diagnostic medical devices. The bills are currently being examined by the competent committees of the Italian Parliament.

Read More
Load More